Physiological Effects of Lung Recruitment During General Anesthesia and Low-tidal Volume Ventilation

NCT ID: NCT03083457

Last Updated: 2021-01-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-20

Study Completion Date

2020-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Low-tidal volume ventilation is arising as a tool to optimize the ventilatory management and to improve clinical outcome in patients undergoing general anesthesia for abdominal surgery.

A recent large randomized controlled trial failed to detect a significant difference between two different approaches for ensuring adequate lung recruitment (PEEP=12 cmH2O + scheduled recruiting maneuvers vs. PEEP 2 cmH2O) during protective ventilation. Thus, in patients undergoing open abdominal surgery and receiving low-tidal volumes, the effects of different positive end-expiratory pressure (PEEP) levels and recruiting maneuvers remain to be established.

Design: prospective, cross-over, physiological trial.

PURPOSE To assess the physiological effects of different PEEP levels with or without scheduled recruiting maneuvers in patients undergoing general anesthesia for open abdominal surgery and receiving low-tidal volume ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anesthesia, General Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Each patient will be randomized to receive or not scheduled recruiting maneuvers every hour. In each of the two groups, patients will receive mechanical ventilation with 3 different levels of PEEP in a sequential, randomized, cross-over manner: each period will last 40 minutes.

A randomization sequence will be produced by a dedicated software and sealed envelopes will be used to allocate patients to study treatments.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PEEP2 + RM

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=2 cmH2O and scheduled recruiting maneuvers at the beginning of each PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

Scheduled recruiting maneuvers

Intervention Type PROCEDURE

Pressure-control ventilation inspiratory pressure=10 cmH2O. Steplike 5-cmH2O-PEEP increase every 30 seconds to achieve a peep of 35 cmH2O, followed by 5-cmH2O-PEEP reduction every 30 seconds to set PEEP

PEEP7 + RM

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=7 cmH2O and scheduled recruiting maneuvers at the beginning of the PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

Scheduled recruiting maneuvers

Intervention Type PROCEDURE

Pressure-control ventilation inspiratory pressure=10 cmH2O. Steplike 5-cmH2O-PEEP increase every 30 seconds to achieve a peep of 35 cmH2O, followed by 5-cmH2O-PEEP reduction every 30 seconds to set PEEP

PEEP12 + RM

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=12 cmH2O and scheduled recruiting maneuvers at the beginning of the PEEP step, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

Scheduled recruiting maneuvers

Intervention Type PROCEDURE

Pressure-control ventilation inspiratory pressure=10 cmH2O. Steplike 5-cmH2O-PEEP increase every 30 seconds to achieve a peep of 35 cmH2O, followed by 5-cmH2O-PEEP reduction every 30 seconds to set PEEP

PEEP2 - RM

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=2 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

PEEP7 - RM

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=7 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

PEEP12 - RM.

General anesthetic, 40 minutes of Low-tidal volume ventilation with PEEP=12 cmH2O, continuous fluid administration at a standard dose, fluid resuscitation or amine administration if deemed necessary by the attending physician blinded to the design of the study

Group Type EXPERIMENTAL

Fluid resuscitation or amine administration

Intervention Type DRUG

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

General anesthetic

Intervention Type DRUG

Total intravenous anesthesia with a standard protocol

Fluid administration

Intervention Type DRUG

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Low-tidal volume ventilation

Intervention Type PROCEDURE

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluid resuscitation or amine administration

Fluid administration or amine administration if deemed necessary by the attending physician. Haemodynamics will be monitored through noninvasive cardiac output assessment by arterial pulse contour analysis

Intervention Type DRUG

General anesthetic

Total intravenous anesthesia with a standard protocol

Intervention Type DRUG

Fluid administration

3-5 ml/kg of balanced crystalloids will be administered throughout the whole surgical procedure

Intervention Type DRUG

Low-tidal volume ventilation

Volume-control ventilation with tidal volume=7 ml/kg of predicted body weight for the entire surgical procedure. Respiratory rate will be set to maintain EtCO2 within a physiological range and kept unchanged for the entire duration of the study

Intervention Type PROCEDURE

Scheduled recruiting maneuvers

Pressure-control ventilation inspiratory pressure=10 cmH2O. Steplike 5-cmH2O-PEEP increase every 30 seconds to achieve a peep of 35 cmH2O, followed by 5-cmH2O-PEEP reduction every 30 seconds to set PEEP

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* ASA physical status I-II patients
* scheduled for open abdominal surgery (major gastrointestinal surgery: duodeno-cephalo-pancreatectomy, gastrectomy, hemi-colectomy; gynecological surgery; oncologic surgery)
* Expected duration of surgery \>= 150 minutes

Exclusion Criteria

* Pregnancy
* BMI\>30 kg/m\^2
* hepatic surgery
* Cardiac failure NYHA\>2
* History of chronic respiratory failure
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Catholic University of the Sacred Heart

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Massimo Antonelli

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Massimo Antonelli, MD

Role: PRINCIPAL_INVESTIGATOR

Catholic University of the Sacred Heart

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

General surgery OR, A. Gemelli hospital

Rome, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

10989/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Low Tidal Volume and EVLWI During OLV
NCT01762709 COMPLETED PHASE1